Login
$CBLL
$26.42 +$0.28 (1.07%) Live

$CBLL SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 144/A
16 Nov 2026 144
13 Nov 2026 Form 4: Burke William W, Director

Received 18,000 shares by exercise or conversion ($84.6K) · Sold 18,000 shares ($479K)

12 Nov 2026 144
10 Nov 2026 Form 4: Taylor Joseph Michael, Director

Sold 10,200 shares ($278K)

09 Nov 2026 144
04 Nov 2026 Form 4: Woo Raymond, Chief Technology Officer

Received 4,887 shares by exercise or conversion ($17.9K) · Sold 4,887 shares ($132K)

03 Nov 2026 10-Q
03 Nov 2026 8-K: Results of Operations and Financial Condition

Sunnyvale, Calif. – November 3, 2026 – CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financi...

02 Nov 2026 144
02 Oct 2026 Form 4: Woo Raymond, Chief Technology Officer

Received 4,887 shares by exercise or conversion ($17.9K) · Sold 4,887 shares ($119K)

01 Oct 2026 144
17 Sep 2026 Form 4: Chao Xingjuan, Director

Sold 20,846 shares ($522K)

17 Sep 2026 Form 4: Blumberg Scott, Chief Financial Officer

Received 846 shares by exercise or conversion ($7.96K) · Sold 846 shares ($21.2K)

15 Sep 2026 144
15 Sep 2026 144
10 Sep 2026 Form 4: Foehr David, Senior VP, Finance and PAO

Sold 9,255 shares ($224K) · Received 7,500 shares by exercise or conversion ($35.3K)

10 Sep 2026 Form 4: Woo Raymond, Chief Technology Officer

Received 13,276 shares by exercise or conversion ($36.7K) · Sold 4,887 shares ($119K)

08 Sep 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support